pharmaceutical investing Novartis Advanced Accelerator Applications Receives FDA Approval for Lutathera
pharmaceutical investing Novartis completes tender offer for Advanced Accelerator Applications S.A. and commencement of subsequent offering period
Advanced Accelerator Applications Announces Pricing of $150 Million Public Offering of American Depositary Shares
ITEL signs agreement with Advanced Accelerator Applications to commercialize F-18 radiopharmaceuticals in Southern Italy
Steadright Removes Titanbeach One Technical Report And Retains Qualified Geologist For New Technical Report
The Metal You've Never Heard Of Is Becoming a National-Security Priority -- and America Barely Mines It